Other languages Johnson & Johnson

Equities

JNJ

US4781601046

Market Closed - Nyse Other stock markets 04:00:05 2024-05-16 pm EDT			After market 06:32:19 pm
154.2 ^USD	+1.02%		153.8	-0.29%

May. 16	Johnson & Johnson to Buy Proteologix For $850 Million in Cash	MT
May. 16	Sector Update: Health Care Stocks Steady Premarket Thursday	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Johnson & Johnson : achète Protéoogix pour combattre la dermatite atopique	05:35am
En Direct des Marchés : Engie, Alstom, Vinci, ADP, Scor, Richemont, Carmat...	02:24am
In diretta dai mercati: Amplifon, ABB, Snam, Salcef, Saipem, Properties, DiaSorin, Tesla, HSBC, Renault, Prosus, Qualcomm, GSK...	02:00am
La Chine toujours tiraillée	01:56am
MÄRKTE USA/Gewinnmitnahmen nach Knacken der 40.000er-Marke beim Dow	May. 16
MÄRKTE USA/Gewinnmitnahmen nach Knacken der 40.000er-Marke beim Dow	May. 16
Johnson & Johnson to Buy Proteologix For $850 Million in Cash	May. 16
MÄRKTE USA/Dow-Jones-Index knackt die Marke von 40.000 Punkten	May. 16
MÄRKTE USA/Neue Rekordstände - US-Daten setzen keine Impulse	May. 16
Sector Update: Health Care Stocks Steady Premarket Thursday	May. 16
MÄRKTE USA/Gut behauptet - Konjunkturdaten setzen keine Impulse	May. 16
Johnson & Johnson Agrees to Acquire Proteologix for $850 Million in Cash	May. 16
Johnson & Johnson : rachat de la biotech Proteologix	May. 16
Johnson & Johnson to acquire Proteologix for $850 million	May. 16
10 attori della bellezza da non perdere	May. 15
Kenvue Prices Secondary Common Stock Offering	May. 15
10 acteurs incontournables de la beauté	May. 14
Top Midday Stories: Return of 'Roaring Kitty' Lifts GameStop Shares; Intel, Apollo Near Deal on Ireland Plant; BHP Latest Offer Rejected by Anglo American; Squarespace Acquired by Permira; Amazon Autonomous Driving Under Probe	May. 13
Johnson & Johnson Offering Notes to Help Fund Shockwave Medical Acquisition	May. 13
J&J : la participation dans Kenvue va être soldée	May. 13

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

January 23, 2024 at 12:30 pm EST